Here, the XPO7-NPAT axis was determined to be a key vulnerability in TP53 mutant AML following genome-wide CRISPR screen in isogenic Trp53-WT and Trp53-KO murine AML models [219]. Here, XPO7 is linked to acute myeloid leukemia.